ArticleJNCI cancer spectrum2018

Effect Sizes Hypothesized and Observed in Contemporary Phase III Trials of Targeted and Immunological Therapies for Advanced Cancer.

Nicola Jane Lawrence et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.